Study identifier:SH-AHM-0016
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
The effect duration of Candesartan Cilexetil (8-16 MG) once daily, in comparison with Enalapril (10-20 MG) once daily, in patients with mild to moderate hypertension.
hypertension
N/A
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|